Related Experiment Video
Updated: Dec 7, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis
Changlei Yao1, Xianghua Cheng1, Xiuquan Guo1
1Department of Urinary Surgery, People's Hospital of Rizhao, No.126, Tai an Street, Dong Gang District, Rizhao, 276826 Shandong China.
Background:
Emerging studies have disclosed long non-coding RNAs (lncRNAs) as pivotal modulators in the progression of prostate cancer (PCa). Current research planned to figure out the involvement of lncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) in PCa.
Methods:
RNA expression was examined using RT-qPCR in PCa cells. Functional assays assessed the viability, proliferation, apoptosis and migration of PCa cells. RNA pull down and luciferase reporter experiments detected the interplay between miRNA and lncRNA or mRNA.
Results:
NNT-AS1 was apparently upregulated in PCa cells. NNT-AS1 deficiency abrogated PCa cell viability, proliferation and migration but promoted apoptosis. Besides, miR-496 could be sequestered by NNT-AS1 to elevate the expression of DNA damage inducible transcript 4 (DDIT4) in PCa. Rescue assays indicated that overexpressed DDIT4 or restrained miR-496 could reverse the influence of NNT-AS1 depletion on malignant processes in PCa cells.
Conclusion:
NNT-AS1 contributes to the malignant phenotypes of PCa cells through targeting miR-496 to boost DDIT4 expression.
Insights
Long non-coding RNA NNT-AS1 promotes prostate cancer (PCa) progression by upregulating DDIT4 expression via sponging miR-496. This finding offers a potential therapeutic target for PCa treatment.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators in prostate cancer (PCa) development.
- The specific role of lncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) in PCa remains largely unexplored.
Purpose of the Study:
- To investigate the functional involvement of NNT-AS1 in the progression of prostate cancer.
- To elucidate the molecular mechanism underlying NNT-AS1's action in PCa cells.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) was used to measure RNA expression levels.
- In vitro functional assays evaluated PCa cell viability, proliferation, apoptosis, and migration.
- RNA pull-down and luciferase reporter assays were employed to determine molecular interactions.
Main Results:
- NNT-AS1 expression was significantly upregulated in PCa cells.
- Depletion of NNT-AS1 inhibited PCa cell viability, proliferation, and migration, while inducing apoptosis.
- NNT-AS1 was found to sequester miR-496, leading to increased expression of DNA damage inducible transcript 4 (DDIT4).
- Rescue experiments confirmed that DDIT4 overexpression or miR-496 inhibition reversed the effects of NNT-AS1 depletion.
Conclusions:
- NNT-AS1 promotes malignant phenotypes in PCa cells.
- This promotion occurs via the NNT-AS1/miR-496/DDIT4 axis.
- NNT-AS1 represents a potential therapeutic target for prostate cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs

